CROSS-IMMUNOGENICITY: ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED IBD PATIENTS SIMILARLY RECOGNIZE THE BIO-SIMILAR REMSIMA
Shomron Ben-Horin 1
Miri Yavzori 1
Orit Picard 1
SooYoung Lee 2
SungHwan Kim 2
Yehuda Chowers 3
1 Sheba Medical Center, Tel-Hashomer, Israel
2 Celltrion, Incheon, Korea, Republic Of
3 Rambam Health Care Campus & Bruce Rappaport School Of Medicine, Technion Institute Of Technology, Haifa, Israel
Conference
UEG Week 2014
Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing